Cargando…

Detection of bacterial co-infections and prediction of fatal outcomes in COVID-19 patients presenting to the emergency department using a 29 mRNA host response classifier

OBJECTIVE: Clinicians in the emergency department (ED) face challenges in concurrently assessing patients with suspected COVID-19 infection, detecting bacterial co-infection, and determining illness severity since current practices require separate workflows. Here we explore the accuracy of the IMX-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ram-Mohan, Nikhil, Rogers, Angela J., Blish, Catherine A., Nadeau, Kari C., Zudock, Elizabeth J, Kim, David, Quinn, James V., Sun, Lixian, Liesenfeld, Oliver, Yang, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936113/
https://www.ncbi.nlm.nih.gov/pubmed/35313598
http://dx.doi.org/10.1101/2022.03.14.22272394
_version_ 1784672155858894848
author Ram-Mohan, Nikhil
Rogers, Angela J.
Blish, Catherine A.
Nadeau, Kari C.
Zudock, Elizabeth J
Kim, David
Quinn, James V.
Sun, Lixian
Liesenfeld, Oliver
Yang, Samuel
author_facet Ram-Mohan, Nikhil
Rogers, Angela J.
Blish, Catherine A.
Nadeau, Kari C.
Zudock, Elizabeth J
Kim, David
Quinn, James V.
Sun, Lixian
Liesenfeld, Oliver
Yang, Samuel
author_sort Ram-Mohan, Nikhil
collection PubMed
description OBJECTIVE: Clinicians in the emergency department (ED) face challenges in concurrently assessing patients with suspected COVID-19 infection, detecting bacterial co-infection, and determining illness severity since current practices require separate workflows. Here we explore the accuracy of the IMX-BVN-3/IMX-SEV-3 29 mRNA host response classifiers in simultaneously detecting SARS-CoV-2 infection, bacterial co-infections, and predicting clinical severity of COVID-19. METHODS: 161 patients with PCR-confirmed COVID-19 (52.2% female, median age 50.0 years, 51% hospitalized, 5.6% deaths) were enrolled at the Stanford Hospital ED. RNA was extracted (2.5 mL whole blood in PAXgene Blood RNA) and 29 host mRNAs in response to the infection were quantified using Nanostring nCounter. RESULTS: The IMX-BVN-3 classifier identified SARS-CoV-2 infection in 151 patients with a sensitivity of 93.8%. Six of 10 patients undetected by the classifier had positive COVID tests more than 9 days prior to enrolment and the remaining oscillated between positive and negative results in subsequent tests. The classifier also predicted that 6 (3.7%) patients had a bacterial co-infection. Clinical adjudication confirmed that 5/6 (83.3%) of the patients had bacterial infections, i.e. Clostridioides difficile colitis (n=1), urinary tract infection (n=1), and clinically diagnosed bacterial infections (n=3) for a specificity of 99.4%. 2/101 (2.8%) patients in the IMX-SEV-3 Low and 7/60 (11.7%) in the Moderate severity classifications died within thirty days of enrollment. CONCLUSIONS: IMX-BVN-3/IMX-SEV-3 classifiers accurately identified patients with COVID-19, bacterial co-infections, and predicted patients’ risk of death. A point-of-care version of these classifiers, under development, could improve ED patient management including more accurate treatment decisions and optimized resource utilization.
format Online
Article
Text
id pubmed-8936113
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-89361132022-03-22 Detection of bacterial co-infections and prediction of fatal outcomes in COVID-19 patients presenting to the emergency department using a 29 mRNA host response classifier Ram-Mohan, Nikhil Rogers, Angela J. Blish, Catherine A. Nadeau, Kari C. Zudock, Elizabeth J Kim, David Quinn, James V. Sun, Lixian Liesenfeld, Oliver Yang, Samuel medRxiv Article OBJECTIVE: Clinicians in the emergency department (ED) face challenges in concurrently assessing patients with suspected COVID-19 infection, detecting bacterial co-infection, and determining illness severity since current practices require separate workflows. Here we explore the accuracy of the IMX-BVN-3/IMX-SEV-3 29 mRNA host response classifiers in simultaneously detecting SARS-CoV-2 infection, bacterial co-infections, and predicting clinical severity of COVID-19. METHODS: 161 patients with PCR-confirmed COVID-19 (52.2% female, median age 50.0 years, 51% hospitalized, 5.6% deaths) were enrolled at the Stanford Hospital ED. RNA was extracted (2.5 mL whole blood in PAXgene Blood RNA) and 29 host mRNAs in response to the infection were quantified using Nanostring nCounter. RESULTS: The IMX-BVN-3 classifier identified SARS-CoV-2 infection in 151 patients with a sensitivity of 93.8%. Six of 10 patients undetected by the classifier had positive COVID tests more than 9 days prior to enrolment and the remaining oscillated between positive and negative results in subsequent tests. The classifier also predicted that 6 (3.7%) patients had a bacterial co-infection. Clinical adjudication confirmed that 5/6 (83.3%) of the patients had bacterial infections, i.e. Clostridioides difficile colitis (n=1), urinary tract infection (n=1), and clinically diagnosed bacterial infections (n=3) for a specificity of 99.4%. 2/101 (2.8%) patients in the IMX-SEV-3 Low and 7/60 (11.7%) in the Moderate severity classifications died within thirty days of enrollment. CONCLUSIONS: IMX-BVN-3/IMX-SEV-3 classifiers accurately identified patients with COVID-19, bacterial co-infections, and predicted patients’ risk of death. A point-of-care version of these classifiers, under development, could improve ED patient management including more accurate treatment decisions and optimized resource utilization. Cold Spring Harbor Laboratory 2022-03-17 /pmc/articles/PMC8936113/ /pubmed/35313598 http://dx.doi.org/10.1101/2022.03.14.22272394 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Ram-Mohan, Nikhil
Rogers, Angela J.
Blish, Catherine A.
Nadeau, Kari C.
Zudock, Elizabeth J
Kim, David
Quinn, James V.
Sun, Lixian
Liesenfeld, Oliver
Yang, Samuel
Detection of bacterial co-infections and prediction of fatal outcomes in COVID-19 patients presenting to the emergency department using a 29 mRNA host response classifier
title Detection of bacterial co-infections and prediction of fatal outcomes in COVID-19 patients presenting to the emergency department using a 29 mRNA host response classifier
title_full Detection of bacterial co-infections and prediction of fatal outcomes in COVID-19 patients presenting to the emergency department using a 29 mRNA host response classifier
title_fullStr Detection of bacterial co-infections and prediction of fatal outcomes in COVID-19 patients presenting to the emergency department using a 29 mRNA host response classifier
title_full_unstemmed Detection of bacterial co-infections and prediction of fatal outcomes in COVID-19 patients presenting to the emergency department using a 29 mRNA host response classifier
title_short Detection of bacterial co-infections and prediction of fatal outcomes in COVID-19 patients presenting to the emergency department using a 29 mRNA host response classifier
title_sort detection of bacterial co-infections and prediction of fatal outcomes in covid-19 patients presenting to the emergency department using a 29 mrna host response classifier
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936113/
https://www.ncbi.nlm.nih.gov/pubmed/35313598
http://dx.doi.org/10.1101/2022.03.14.22272394
work_keys_str_mv AT rammohannikhil detectionofbacterialcoinfectionsandpredictionoffataloutcomesincovid19patientspresentingtotheemergencydepartmentusinga29mrnahostresponseclassifier
AT rogersangelaj detectionofbacterialcoinfectionsandpredictionoffataloutcomesincovid19patientspresentingtotheemergencydepartmentusinga29mrnahostresponseclassifier
AT blishcatherinea detectionofbacterialcoinfectionsandpredictionoffataloutcomesincovid19patientspresentingtotheemergencydepartmentusinga29mrnahostresponseclassifier
AT nadeaukaric detectionofbacterialcoinfectionsandpredictionoffataloutcomesincovid19patientspresentingtotheemergencydepartmentusinga29mrnahostresponseclassifier
AT zudockelizabethj detectionofbacterialcoinfectionsandpredictionoffataloutcomesincovid19patientspresentingtotheemergencydepartmentusinga29mrnahostresponseclassifier
AT kimdavid detectionofbacterialcoinfectionsandpredictionoffataloutcomesincovid19patientspresentingtotheemergencydepartmentusinga29mrnahostresponseclassifier
AT quinnjamesv detectionofbacterialcoinfectionsandpredictionoffataloutcomesincovid19patientspresentingtotheemergencydepartmentusinga29mrnahostresponseclassifier
AT sunlixian detectionofbacterialcoinfectionsandpredictionoffataloutcomesincovid19patientspresentingtotheemergencydepartmentusinga29mrnahostresponseclassifier
AT liesenfeldoliver detectionofbacterialcoinfectionsandpredictionoffataloutcomesincovid19patientspresentingtotheemergencydepartmentusinga29mrnahostresponseclassifier
AT detectionofbacterialcoinfectionsandpredictionoffataloutcomesincovid19patientspresentingtotheemergencydepartmentusinga29mrnahostresponseclassifier
AT yangsamuel detectionofbacterialcoinfectionsandpredictionoffataloutcomesincovid19patientspresentingtotheemergencydepartmentusinga29mrnahostresponseclassifier